Twitter Facebook Linkedin Envelope Freiburg, Germany – August 5, 2019 – The owners of Cytena GmbH (“Cytena”) have agreed to sell all CYTENA shares to CELLINK AB (“CELLINK”) for a purchase price of 30.25M euros (“acquisition”). Through CELLINK’s complimentary technology offering CYTENA sees great synergies that will support and accelerate future growth of CYTENA. An extended product offering and a …
Twitter Facebook Linkedin Envelope Freiburg, Germany – July 23, 2019 – CYTENA, the specialist for single-cell technologies, is continuing its growth with the establishment of its subsidiary CYTENA Bioprocess Solutions in Taiwan. CYTENA Bioprocess Solutions is developing an innovative technology, which enables considerable reductions in time and increases in efficiency for cell line development. “With the new R&D …
Twitter Facebook Linkedin Envelope The “Mono-cy-clone” project was funded by the Federal Ministry of Education and Research with 1.5 million euros as part of the “KMU-innovativ: Biotechnologie-BioChance” programme from January 2016 to July 2019. With the help of the project, the single-cell printer already launched by cytena in 2015 could be further developed. The new goal was to select …
Twitter Facebook Linkedin Envelope Two private investors and High-Tech Gründerfonds (HTGF) are convinced of the importance of single-cell isolation for the production of biopharmaceuticals and for genetic analysis in research and diagnostics. EUR 3 million will be invested in the further development of the technology, the expansion of the sales organization and in opening up …
EUR 3 million in series A for the growth and development of CYTENA GmbH Read More »
Twitter Facebook Linkedin Envelope Our long-time customer Genentech in San Francisco has rated our single-cell printer with 4.3 out of 5 points. “Leading instrument and great results”. Especially the value for money and the after sales service were rated as excellent. CYTENA thanks Genentech for this great review.Click here to read the full review.
Twitter Facebook Linkedin Envelope Freiburg, Germany — CYTENA was distinguished with the Innovation Award of Baden-Württemberg, one of the most economically powerful and competitive regions in Europe. Since 1985, the Ministry of Economics recognizes small and medium-sized enterprises for their innovative products, processes and services. The Ministry of Economics awarded 50,000€ in prize money in dedication to the …
CYTENA is a part of BICO. Our products aim to reduce the
organ shortage and speed up drug development by
providing accessible life science solutions that combine
biology and technology, fundamentally shifting the global healthcare industry.
Read more at BICO.com
⚡Discover the C.STATION™ – Combine Single-Cell Cloning, Upscaling And Clone Selection All In One Unit. See How.
